Ligand Pharmaceuticals | LGND - 流動負債

株価
231.27
毎日の変更
2.79 1.22%
毎月
13.06%
毎年
114.00%
Q2 予測
226.32




流動負債 変化する 日付
Agenus USD 323.49M 36.36M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Anika Therapeutics USD 21.91M 2.82M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Baxter International USD 2.97B 805M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Enviri Corporation USD 634.02M 5.4M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Glaxosmithkline GBP 28.82B 144.79M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Merck USD 28.63B 2.59B 2025-09
Pacira USD 120.59M 13.51M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Veracyte USD 59.94M 12.22M 2025-12